Strategos Medical Group — Bakersfield, California

Strategos Medical Group is a clinical research site located in Bakersfield, California, United States 93311.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Strategos Medical Group has participated in 1 clinical trials.

Therapeutic areas: Diabetes.

Sponsors: AstraZeneca.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bakersfield

Browse all research sites in California · View every site in Bakersfield

• Bakersfield VA Clinic, VA Greater Los Angeles Healthcare System
• Good Samaritan Hospital
• Bakersfield Memorial Hospital
• AIS Cancer Center at San Joaquin Community Hospital
• Bakersfield Heart Hospital
• Comprehensive Blood and Cancer Center
• Research Site
• GSK Investigational Site
• California Retina Consultants
• Kern Research
• Empire Eye & Laser Center
• CBCC Global Research at Comprehensive Blood and Cancer Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Strategos Medical Group?

Strategos Medical Group has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Strategos Medical Group conducted?

Strategos Medical Group has 1 clinical trials on record. Their work covers Diabetes.

Is Strategos Medical Group accredited by Crixeo Clinical Trials?

Strategos Medical Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Strategos Medical Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.